Medical Devices New Zealand

New Zealand Kidney Function Tests Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

New Zealand Kidney Function Tests Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.5 Mn Placeholder estimate
Estimate 2025 $19.6 Mn 0.9% of the global market
Projected 2034 $33.4 Mn 70.4% Adds $13.8 Mn over 9 forecast years
CAGR 2025–2034 6.1% Faster than 10% of 147 Medical Devices markets here
Key players 5
  • New Zealand is 0.87% of the global market.
  • In APAC, the largest is China at $191.5 Mn.
  • Fastest growing: India at 9.3% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$13.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Kidney Function Tests Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.5 Mn — —
2025 (base) $19.6 Mn +$1.1 Mn —
2026 (forecast) $20.8 Mn +$1.2 Mn +6.1%
2027 (forecast) $22.1 Mn +$1.3 Mn +12.6%
2028 (forecast) $23.4 Mn +$1.3 Mn +19.4%
2029 (forecast) $24.8 Mn +$1.4 Mn +26.7%
2030 (forecast) $26.3 Mn +$1.5 Mn +34.5%
2031 (forecast) $27.9 Mn +$1.6 Mn +42.7%
2032 (forecast) $29.6 Mn +$1.7 Mn +51.4%
2033 (forecast) $31.5 Mn +$1.8 Mn +60.6%
2034 (forecast) $33.4 Mn +$1.9 Mn +70.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.25 Bn
  2. US $1.02 Bn
  3. North America $968.4 Mn
  4. APAC $503.7 Mn
  5. Europe $390.6 Mn
  6. China $191.5 Mn
  7. Canada $166.3 Mn
  8. Japan $161.5 Mn
  9. Middle East $103.0 Mn
  10. Latin America $97.9 Mn
  11. Germany $69.8 Mn
  12. France $64.8 Mn
  13. Brazil $59.1 Mn
  14. UK $50.4 Mn
  15. Italy $48.5 Mn
  16. Spain $40.8 Mn
  17. Saudi Arabia $40.8 Mn
  18. Ecuador $39.8 Mn
  19. India $37.4 Mn
  20. Africa $36.1 Mn
  21. Mexico $30.3 Mn
  22. Australia $30.6 Mn
  23. Russia $20.3 Mn
  24. New Zealand (this report) $19.6 Mn
  25. South Africa $12.9 Mn
  26. UAE $10.6 Mn
  27. Egypt $6.8 Mn
  28. Philippines $4.6 Mn
  29. Malaysia $3.9 Mn
  30. Thailand $3.2 Mn
  31. Hong Kong $3.1 Mn
  32. Singapore $3.1 Mn
  33. Kenya $1.4 Mn

Report snapshot

New Zealand Kidney Function Tests Market Analysis at a glance
Market size, 2025$19.6 Mn placeholder estimate
Forecast, 2034$33.4 Mn placeholder estimate
Growth (CAGR), 2025–20346.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, setting and end user (see all)
Key playersRoche Diagnostics, Siemens Healthineers, Abbott Laboratories, Healthy.io, Nova Biomedical (see all)
Regulator in New ZealandMedsafe (WAND)Source: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Kidney Function Tests Market Analysis Executive Summary

Kidney function tests measure creatinine, protein in urine and other markers to find and track kidney disease.

Key segments of the kidney Function Tests market include test (Serum Creatinine, eGFR and Urine Albumin) and setting (Labs, Point of Care and Home).

Bar chart: New Zealand Kidney Function Tests market size, 2024–2034, placeholder estimates. $18.5 Mn in 2024, $19.6 Mn in 2025 and $33.4 Mn in 2034, 6.1% CAGR.
New Zealand Kidney Function Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Kidney Function Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the kidney Function Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the kidney Function Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the kidney Function Tests market.

Competitive Landscape for Kidney Function Tests Market in New Zealand

The kidney Function Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Kidney Function Tests Market in New Zealand

Kidney Function Tests in New Zealand: rules and payment

Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how kidney Function Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Kidney Function Tests right now, from free public sources.

Latest research 466 papers since 2021 (worldwide)

  1. Evaluating CKD-EPI Pakistan Against Standard Equations Using Diethylenetriaminepentaacetic Acid-Measured Glomerular Filtration Rate. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2026
  2. Model-Derived Iopamidol Clearance and Creatinine-Based Kidney Function Estimates After Trauma: A Retrospective Cohort Study. Pharmacotherapy, 2026
  3. Peri-treatment Creatinine-Based eGFR Trajectories in Patients Receiving Breast Radiotherapy: A Retrospective Cohort Study. The oncologist, 2026
  4. Lethal Vespa tropica Sting: Clinical Presentation, Autopsy Findings, and Histopathological Observations: A Case Report. Academic forensic pathology, 2026
  5. Association of Serum Magnesium Concentration With Microvascular Complications Among Patients Diagnosed With Type 2 Diabetes Mellitus: An Observational Cross-Sectional Analysis. Cureus, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Kidney Function Tests in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Kidney Function Tests market in New Zealand?
Placeholder estimate: about $19.6 Mn in 2025, rising to about $33.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Kidney Function Tests market in New Zealand growing?
Placeholder estimate: about 6.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Kidney Function Tests market report cover?
The report splits the market by test (Serum Creatinine, eGFR, Urine Albumin, Cystatin C and more), setting (Labs, Point of Care, Home) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Kidney Function Tests market?
Key players include Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Healthy.io and Nova Biomedical.
What is driving the Kidney Function Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the kidney Function Tests market.
Who regulates Kidney Function Tests in New Zealand?
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Kidney Function Tests?
PubMed lists 466 papers on Kidney Function Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Kidney Function Tests in New Zealand? Our analysts can size it for your plan. Talk to us See the public data Kidney disease death rate for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in New Zealand

See all
Same topic, other categories

Related on diagnostics and lab testing and kidney health

See the topic